REPROCELL and BioBridge Global sign Memorandum of Understanding to accelerate global manufacturing services using clinical iPSCs

Large volume transfusion with whole blood is safe compared with component therapy

Leave a Reply

Your email address will not be published. Required fields are marked *

Search
Close this search box.